Health Condition 1: K210- Gastro-esophageal reflux disease with esophagitis
Conditions
Interventions
Intervention1: Nebulization with dexmeditomidine: Nebulization with dexmeditomide is given at dose of 1mcg/kg , 30 minutes prior to intubation.
Control Intervention1: NEBULIZATION WITH NORMAL SALINE:
Sponsors
Joseph Sebastian
Eligibility
Inclusion criteria
Inclusion criteria: ASA (American Society of Anesthesiologists) physical status I- II,111, and undergoing third space endoscopies.
Exclusion criteria
Exclusion criteria: Patients with severe respiratory disease, cardiac disease, or neurological disorders, those with a history of dexmedetomidine allergy or intolerance, not willing for study, pregnancy, ASA 4 and above ,refusal of consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hemodynamic stability with nebulized dexmedetomidine as premedication during third space endoscopy procedures, as measured by heart rate, blood pressure .Timepoint: 30 minutes prior to intubation till 20 minutes after extubation. | — |
Secondary
| Measure | Time frame |
|---|---|
| To know the hemodynamic response of nebulized dexmedetomidine as premedication for the attenuation of the laryngoscopy and intubation response To assess the incidence of adverse events associated with nebulized dexmedetomidine such as hypotension, bradycardia Timepoint: 30 minutes prior to intubation till 20 minutes after extubation. | — |
Countries
India
Contacts
Public ContactNisha A
Aster Medcity
Outcome results
None listed